Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05868902 · ClinicalTrials.gov registry record
A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.
A clinical trial of Coronary; Ischemic, sponsored by Genetesis.
- Recruiting
- Registry status
- 300
- Enrollment target
- 2
- Study locations
NCT05868902: Recruiting study of Coronary; Ischemic, sponsored by Genetesis.
NCT05868902 is a study of Coronary; Ischemic that is actively recruiting participants, run by Genetesis. The registered enrollment target is 300 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05868902, a study of Coronary; Ischemic, is actively recruiting participants, sponsored by Genetesis.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.
Conditions Studied
Interventions
- DEVICE CardioFlux Magnetocardiography
Study Locations (2)
Ohio
- Cleveland Clinic - Cleveland
- Kettering Health - Kettering
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-08-28 |
| Est. Completion | 2025-12-31 |
What NCT05868902 shows while recruiting
NCT05868902 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Coronary; Ischemic appearing as the primary indexed condition, and to 1 intervention - of which CardioFlux Magnetocardiography is the first listed.
NCT05868902 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05868902 about?
NCT05868902 is a clinical study titled "A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.". A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.
What is the current status of trial NCT05868902?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2023-08-28. Estimated completion is 2025-12-31.
What conditions does trial NCT05868902 study?
This clinical trial studies the following conditions: Coronary; Ischemic.
What interventions are being tested in trial NCT05868902?
The interventions under investigation include: CardioFlux Magnetocardiography (DEVICE).
Who is sponsoring clinical trial NCT05868902?
This trial is sponsored by Genetesis, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05868902 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI